Published in Immunol Rev on April 01, 2008
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med (2011) 4.02
Apoptotic cell blebs: repositories of autoantigens and contributors to immune context. Arthritis Rheum (2009) 1.53
Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci U S A (2010) 1.46
A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients. Proteome Sci (2013) 1.44
Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer. Scand J Immunol (2015) 1.42
Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn (2010) 1.23
Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett (2009) 1.16
Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res (2008) 1.13
Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. J Proteome Res (2011) 1.11
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
A high-throughput O-glycopeptide discovery platform for seromic profiling. J Proteome Res (2010) 1.00
Tumor-associated autoantibodies as diagnostic and prognostic biomarkers. BMB Rep (2012) 0.99
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev (2010) 0.97
An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions. Anal Bioanal Chem (2010) 0.96
Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform. J Immunol Methods (2010) 0.94
Autoantibodies, autoimmune disease, and the birth of immune diagnostics. J Clin Invest (2012) 0.90
Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma. Int J Oncol (2012) 0.89
Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors. PLoS One (2009) 0.89
APOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy. PLoS One (2009) 0.88
Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma. World J Gastroenterol (2011) 0.87
Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Oncol Lett (2012) 0.86
Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma. Melanoma Res (2011) 0.85
Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC). Exp Hematol Oncol (2013) 0.85
Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors. Oncol Lett (2012) 0.85
Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis. J Proteome Res (2013) 0.84
The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med (2015) 0.83
Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women. Cancer Epidemiol Biomarkers Prev (2014) 0.83
Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. Autoimmun Rev (2013) 0.83
Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. J Immunol Res (2014) 0.83
Differential influence of anticancer treatments and angiogenesis on the seric titer of autoantibody used as tumor and metastasis biomarker. Neoplasia (2010) 0.83
Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma. Oncol Rep (2013) 0.83
Autoimmune response to PARP and BRCA1/BRCA2 in cancer. Oncotarget (2015) 0.83
CIG-DB: the database for human or mouse immunoglobulin and T cell receptor genes available for cancer studies. BMC Bioinformatics (2010) 0.83
Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis. Tumour Biol (2014) 0.83
Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma. J Clin Endocrinol Metab (2009) 0.82
Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers. PLoS One (2013) 0.81
Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer. Int J Oncol (2012) 0.80
TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy. Oncoimmunology (2012) 0.79
Identification of plasma protein profiles associated with risk groups of prostate cancer patients. Proteomics Clin Appl (2014) 0.79
Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. J Immunol Res (2014) 0.79
Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis. Tumour Biol (2014) 0.78
Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clin Immunol (2014) 0.78
Tumor-associated antigen CAPERα and microvessel density in hepatocellular carcinoma. Oncotarget (2016) 0.78
Autoantibodies to mesothelin in infertility. Cancer Epidemiol Biomarkers Prev (2011) 0.78
Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. J Exp Med (2016) 0.77
Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer. J Immunol Res (2014) 0.77
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases. Clin Dev Immunol (2013) 0.77
Antinuclear antibodies defining autoimmunity pathways. Arthritis Res Ther (2014) 0.77
Autoantibody against hypoxia-inducible factor prolyl hydroxylase-3 is a potential serological marker for renal cell carcinoma. J Cancer Res Clin Oncol (2010) 0.77
FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer. Int J Clin Oncol (2015) 0.77
Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget (2016) 0.76
Anti-HE4 antibodies in infertile women and women with ovarian cancer. Gynecol Oncol (2013) 0.76
Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma. PLoS One (2011) 0.76
Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins. Mol Cell Proteomics (2016) 0.76
CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer. BMC Cancer (2015) 0.75
Cancer immunology and cancer immunodiagnosis. J Immunol Res (2014) 0.75
Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer. Oncoimmunology (2016) 0.75
Binding of circulating autoantibodies in breast cancer to native and peroxynitrite-modified RNA. J Zhejiang Univ Sci B (2013) 0.75
Autoimmunity and tumor immunology: two facets of a probabilistic immune system. BMC Syst Biol (2014) 0.75
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag. Genes Cancer (2016) 0.75
The network of antigen-antibody reactions in adult women with breast cancer or benign breast pathology or without breast pathology. PLoS One (2015) 0.75
Identification of Novel and Noninvasive Biomarkers of Acute Cellular Rejection After Liver Transplantation by Protein Microarray. Transplant Direct (2016) 0.75
Recognition of tumor antigens in 4T1 cells by natural IgM from three strains of mice with different susceptibilities to spontaneous breast cancer. Oncol Lett (2016) 0.75
Potential biomarkers for esophageal cancer. Springerplus (2016) 0.75
Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies. Microarrays (Basel) (2015) 0.75
Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer. PLoS One (2015) 0.75
Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer. Oncoimmunology (2017) 0.75
Conserved structures and diversity of functions of RNA-binding proteins. Science (1994) 14.75
Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol (1989) 8.02
Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature (1987) 6.45
A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol (1999) 5.58
Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med (1975) 5.00
Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med (2002) 4.54
Smooth muscle antibody in malignant disease. Br Med J (1971) 4.54
An auxiliary protein for DNA polymerase-delta from fetal calf thymus. J Biol Chem (1986) 4.06
Precursor molecules of both human 5S ribosomal RNA and transfer RNAs are bound by a cellular protein reactive with anti-La lupus antibodies. Cell (1982) 3.76
A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences. Proc Natl Acad Sci U S A (1981) 3.68
Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc Natl Acad Sci U S A (1999) 3.61
Epitopes on protein antigens: misconceptions and realities. Cell (1990) 3.32
p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res (2000) 3.31
Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer (1982) 2.98
A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med (1981) 2.82
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science (1986) 2.50
Injection of anticentromere antibodies in interphase disrupts events required for chromosome movement at mitosis. J Cell Biol (1990) 2.46
A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med (1999) 2.36
Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest (2001) 2.35
Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem (1989) 2.33
The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res (2005) 2.22
Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ (1991) 2.20
Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 2.14
Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res (1992) 2.09
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res (2006) 2.08
Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest (1987) 1.99
Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today (1997) 1.91
The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. Nucleic Acids Res (1998) 1.82
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest (2001) 1.81
Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies. Clin Immunol (2001) 1.78
Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J Exp Med (1987) 1.76
Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res (2003) 1.72
Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest (1993) 1.66
Epitopes, structural domains, and asymmetry of amino acid residues in SS-B/La nuclear protein. J Immunol (1986) 1.63
Serum p53 antibodies as early markers of lung cancer. Nat Med (1995) 1.63
Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med (1996) 1.52
Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res (1988) 1.51
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol (2001) 1.49
Analysis of the anti-p53 antibody response in cancer patients. Cancer Res (1993) 1.49
Hepatitis B virus, the vaccine, and the control of primary cancer of the liver. Proc Natl Acad Sci U S A (1997) 1.45
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface. Cancer Res (1993) 1.41
Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res (1988) 1.41
Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer (1993) 1.37
Multiplexed protein array platforms for analysis of autoimmune diseases. Annu Rev Immunol (2006) 1.32
Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci U S A (1993) 1.32
Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest (2003) 1.32
Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I. Chromosoma (1986) 1.30
Cancer vaccines: progress reveals new complexities. J Clin Invest (2002) 1.29
Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res (1996) 1.29
Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu Rev Neurosci (2001) 1.29
Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol (1990) 1.28
Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J Exp Med (2001) 1.26
Apoptosis and autoimmunity. Curr Opin Immunol (2005) 1.25
Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein. Cancer Res (2000) 1.25
T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease. Clin Cancer Res (2005) 1.24
Thyroid autoimmunity. J Clin Invest (2001) 1.24
Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Prostate (2005) 1.19
Insulin-like growth factors: the unrecognised oncogenes. Br J Cancer (1995) 1.17
Autoantibody to the proliferating cell nuclear antigen neutralizes the activity of the auxiliary protein for DNA polymerase delta. Nucleic Acids Res (1987) 1.16
Inefficient clearance of dying cells and autoreactivity. Curr Top Microbiol Immunol (2006) 1.16
Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst (1995) 1.15
Autoreactive epitope defined as the anticodon region of alanine transfer RNA. Science (1987) 1.14
Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. J Gen Virol (1989) 1.13
C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors. Int J Cancer (2001) 1.11
Immune response to cyclin B1 in hepatocellular carcinoma. Hepatology (1997) 1.09
A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis (2000) 1.09
Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics (2001) 1.08
Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53. Mol Immunol (2002) 1.07
Interactions between autoimmunity and molecular and cell biology. Bridges between clinical and basic sciences. J Clin Invest (1989) 1.04
Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer. Cancer Res (2006) 1.03
Myositis autoantibody reactivity and catalytic function of threonyl-tRNA synthetase. FASEB J (1988) 1.02
Insights into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products. J Exp Med (1990) 1.00
An efficient proteomics-based approach for the screening of autoantibodies. J Immunol Methods (2005) 0.99
Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries. Eur J Immunol (2001) 0.99
The small nuclear ribonucleoprotein SS-B/La binds RNA with a conserved protease-resistant domain of 28 kilodaltons. Mol Cell Biol (1987) 0.99
Paraneoplastic syndromes. Curr Opin Immunol (1997) 0.98
A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library. J Immunol (2002) 0.98
Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases. Clin Immunol Immunopathol (1975) 0.97
Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display. Cancer Immunol Immunother (2004) 0.96
Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin Exp Immunol (1999) 0.93
Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. J Immunol (1987) 0.91
Relative paradigms between autoantibodies in lupus and autoantibodies in cancer. Clin Exp Immunol (2003) 0.90
Improved approach to identify cancer-associated autoantigens. Autoimmun Rev (2004) 0.89
Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma. Cancer Res (1983) 0.87
Autoantibodies in viral hepatitis-related hepatocellular carcinoma. Intervirology (1993) 0.86
Synthetic compound peptide simulating antigenicity of conformation-dependent autoepitope. J Biol Chem (1994) 0.86
Peptide immunogen mimicry of a protein-specific structural epitope on human choriogonadotropin. Science (1990) 0.84
Autoantibody to DNA topoisomerase II in primary liver cancer Clin Cancer Res (1995) 0.82
Plant DNA topoisomerase I is recognized and inhibited by human Scl-70 sera autoantibodies. Exp Cell Res (1990) 0.81
Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword. J Clin Invest (2003) 0.81
Autoantibodies in cancer patients. Pathology (1977) 0.79
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood (2010) 2.41
Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell (2012) 2.01
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood (2009) 1.94
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells. Blood (2010) 1.60
Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer (2005) 1.50
Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate (2005) 1.48
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect. Blood (2011) 1.41
Computational studies on the crystal structure, thermodynamic properties, detonation performance, and pyrolysis mechanism of 2,4,6,8-tetranitro-1,3,5,7-tetraazacubane as a novel high energy density material. J Phys Chem A (2011) 1.36
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. J Clin Invest (2011) 1.30
Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS One (2009) 1.26
MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood (2013) 1.15
Increasing hospital volume is not associated with improved survival in out of hospital cardiac arrest of cardiac etiology. Resuscitation (2012) 1.15
Twelve-month diagnosed prevalence of behavioral health disorders among elderly medicare and medicaid members. Am J Geriatr Psychiatry (2011) 1.09
In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. J Immunol (2010) 1.09
The effect of multifunctional polymer-based gels on wound healing in full thickness bacteria-contaminated mouse skin wound models. Biomaterials (2007) 1.08
Beyond health plans: behavioral health disorders and quality of diabetes and asthma care for Medicaid beneficiaries. Med Care (2009) 1.08
QUAL2K model used in the water quality assessment of Qiantang River, China. Water Environ Res (2008) 1.06
Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus. Mol Ther (2011) 1.05
Chronic physical conditions in older adults with mental illness and/ or substance use disorders. J Am Geriatr Soc (2011) 1.05
Maternal Characteristics, Pregnancy Complications, and Adverse Birth Outcomes Among Women With Disabilities. Med Care (2015) 1.05
Health care utilization patterns of homeless individuals in Boston: preparing for Medicaid expansion under the Affordable Care Act. Am J Public Health (2013) 1.04
Theoretical studies on the heats of formation, detonation properties, and pyrolysis mechanisms of energetic cyclic nitramines. J Phys Chem A (2011) 1.00
The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway. Basic Res Cardiol (2012) 0.98
The diversity expression of p62 in digestive system cancers. Clin Immunol (2005) 0.98
Predictors of prenatal and postpartum care adequacy in a medicaid managed care population. Womens Health Issues (2011) 0.98
Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J Hepatol (2010) 0.96
Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillation. Circ Arrhythm Electrophysiol (2013) 0.96
XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep (2012) 0.92
Treadmill running exercise results in the presence of numerous myofibroblasts in mouse patellar tendons. J Orthop Res (2009) 0.92
Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis. J Thorac Oncol (2015) 0.90
Prevalence and risk factors for postpartum depression symptoms among women with disabilities. Matern Child Health J (2015) 0.90
CD94 defines phenotypically and functionally distinct mouse NK cell subsets. J Immunol (2009) 0.90
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease. Blood (2013) 0.90
Antimicrobial activities of silver used as a polymerization catalyst for a wound-healing matrix. Biomaterials (2006) 0.89
XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies. Int J Cancer (2009) 0.89
Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma. Int J Oncol (2012) 0.89
Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma. Cancer Lett (2009) 0.88
Superparamagnetic iron oxide is suitable to label tendon stem cells and track them in vivo with MR imaging. Ann Biomed Eng (2013) 0.88
Serum autoantibodies in the early detection of esophageal cancer: a systematic review. Tumour Biol (2014) 0.87
Dioxin-like compounds in agricultural soils near e-waste recycling sites from Taizhou area, China: chemical and bioanalytical characterization. Environ Int (2008) 0.86
Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Oncol Lett (2012) 0.86
Behavioral disorders and diabetes-related outcomes among Massachusetts Medicare and Medicaid beneficiaries. Psychiatr Serv (2011) 0.86
Antidepressant adequacy and work status among medicaid enrollees with disabilities: a restriction-based, propensity score-adjusted analysis. Community Ment Health J (2009) 0.85
Behavioral health disorders and adherence to measures of diabetes care quality. Am J Manag Care (2011) 0.85
Inflammatory cytokine gene polymorphisms in gastric cancer cases' and controls' family members from Chinese areas at high cancer prevalence. Cancer Lett (2008) 0.85
Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer. Int J Oncol (2012) 0.84
A theoretical study on 1,5-diazido-3-nitrazapentane (DANP) and 1,7-diazido-2,4,6-trinitrazaheptane (DATNH): molecular and crystal structures, thermodynamic and detonation properties, and pyrolysis mechanism. J Mol Model (2013) 0.84
Effect of Angelica sinensis on the proliferation of human bone cells. Clin Chim Acta (2002) 0.84
Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma. Oncol Rep (2013) 0.83
Phosphorus interception in floodwater of paddy field during the rice-growing season in TaiHu Lake Basin. Environ Pollut (2006) 0.82
Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis. Diagn Pathol (2013) 0.82
Effect of surface coating and organic matter on the uptake of CeO2 NPs by corn plants grown in soil: Insight into the uptake mechanism. J Hazard Mater (2012) 0.82
Rapid detection of Shigella species in environmental sewage by an immunocapture PCR with universal primers. Appl Environ Microbiol (2002) 0.82
Unmet need for disability-related health care services and employment status among adults with disabilities in the Massachusetts Medicaid program. Disabil Health J (2011) 0.81
Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profiles. Acta Biomater (2008) 0.81
MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart. J Cardiovasc Pharmacol (2015) 0.80
Association of single nucleotide polymorphisms in ERCC2 gene and their haplotypes with esophageal squamous cell carcinoma. Tumour Biol (2014) 0.80
Relationship between nerve injury-induced protein gene 2 polymorphism and stroke in Chinese Han population. J Biomed Res (2011) 0.80
Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population. Cancer Epidemiol (2013) 0.80
Disassembly and degradation of photosystem I in an in vitro system are multievent, metal-dependent processes. J Biol Chem (2003) 0.80
Cyclooxygenase-2 polymorphisms and the risk of gastric cancer in various degrees of relationship in the Chinese Han population. Oncol Lett (2011) 0.79
Gastric cancer susceptibility in gastric cancer relatives: attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori. Cytokine (2012) 0.79
LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomas. Acta Biomater (2007) 0.78
Effect of Agkistroden blomhoffi (mamushi) on the proliferation of human fibroblasts. Clin Biochem (2004) 0.78
MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma. Mol Genet Genomics (2014) 0.78
hsp70 and a novel axis of type I interferon-dependent antiviral immunity in the measles virus-infected brain. J Virol (2012) 0.78
Reaction-diffusion systems and external morphogen gradients: the two-dimensional case, with an application to skeletal pattern formation. Bull Math Biol (2011) 0.78
Use of aminoglycoside adenyltransferase translational fusions to determine topology of thylakoid membrane proteins. FEBS Lett (2003) 0.77
[Meta-analysis of the relationship between polymorphisms of 399 point of X-ray repair cross complementing gene group 1 and hepatocellular carcinoma]. Wei Sheng Yan Jiu (2010) 0.77
Incorporation of ionic ligands accelerates drug release from LDI-glycerol polyurethanes. Acta Biomater (2009) 0.77
Immuno-capture PCR for detection of Aeromonas hydrophila. J Microbiol Methods (2002) 0.77
Degradative-release as a function of drug structure from LDI-glycerol polyurethanes. Biomed Mater Eng (2010) 0.76
Simultaneous drug release at different rates from biodegradable polyurethane foams. Acta Biomater (2009) 0.76
Protective effects of adenosine on the diabetic myocardium against ischemia-reperfusion injury: role of calpain. Med Hypotheses (2012) 0.75
HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility. Oncol Lett (2012) 0.75
Disparities in routine breast cancer screening for Medicaid managed care members with a work-limiting disability. Medicare Medicaid Res Rev (2011) 0.75
Biological phosphorus removal performance and relevant microorganism characteristics of activated sludge in municipal wastewater treatment plants, China. Water Environ Res (2011) 0.75
Numerical method based on the lattice Boltzmann model for the Fisher equation. Chaos (2008) 0.75
Influence of submission form characteristics on clinical information received in biopsy accession. J Vet Diagn Invest (2012) 0.75
Access to B=S and B=Se double bonds via sulfur and selenium insertion into a B-H bond and hydrogen migration. J Am Chem Soc (2010) 0.75
Synthesis, structure, and reactivity of a monomeric iminoalane. Chemistry (2012) 0.75
Genetic epidemiological analysis reveals a multi-gene additive model for gastric cancer. Fam Cancer (2011) 0.75
Isolation of a 1,2-dialuminacyclobutene. Angew Chem Int Ed Engl (2006) 0.75
Use of fugacity model to analyze temperature-dependent removal of micro-contaminants in sewage treatment plants. Chemosphere (2011) 0.75
N-Aryl substituted heterocyclic silylenes. Dalton Trans (2009) 0.75
Sol-gel-Derived highly sensitive optical oxygen sensing materials using Ru(II) complex via covalent grafting strategy. J Nanosci Nanotechnol (2014) 0.75
Measurement of transporter associated with antigen processing 1 and tumor necrosis factor alpha expression in hepatitis B virus-related hepatocellular carcinoma and peritumor cirrhosis tissues using tissue chip technology. Hepatogastroenterology (2013) 0.75
[Genetic polymorphisms of ADH1B and ALDH-2 associated with risk of esophageal cancer: a meta-analysis]. Wei Sheng Yan Jiu (2012) 0.75
Development of a novel adenosine-eluting guidewire (Adenowire) for coronary vasodilation during percutaneous coronary intervention. EuroIntervention (2014) 0.75
2-chloro-azaborolyl anion: a source of 1,2-azaborole isosteric to cyclopentadienylidene. Chemistry (2014) 0.75
One-step access to luminescent pentaaryldiazaboroles via C-C double bond formation from imidoylstannanes. J Am Chem Soc (2012) 0.75
[Study on effect of lead exposure to blood lead level and hearing in young offspring through gestation-rat]. Lin Chuang Er Bi Yan Hou Ke Za Zhi (2006) 0.75
In vitro investigations for the QSAR mechanism of lymphocytes apoptosis induced by substituted aromatic toxicants. Fish Shellfish Immunol (2008) 0.75
Simple stochastic lattice gas automaton model for formation of river networks. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.75
Effect of Agkistroden blomhoffi (mamushi) on superoxide generation in human neutrophils. Clin Biochem (2006) 0.75
[Urban greenbelt eco-service value of Hangzhou City under effects of land use change: an evaluation with CITYgreen model]. Ying Yong Sheng Tai Xue Bao (2006) 0.75
Isolable 1,1-disubstituted silole dianion: a homogeneous two-electron-transfer reducing reagent. Inorg Chem (2014) 0.75
Comparison of anionic and lewis acid stabilized N-heterocyclic oxoboranes: their facile synthesis from a borinic acid. Angew Chem Int Ed Engl (2011) 0.75
[Discussion to the advanced application of scripting in RayStation TPS system]. Zhongguo Yi Liao Qi Xie Za Zhi (2014) 0.75
Monogenea of Chinese marine fishes. XVIII. Two monocotylids, including a new species, from the blotched fantail ray Taeniurops meyeni (Elasmobranchii: Dasyatidae) in the South China Sea. Folia Parasitol (Praha) (2010) 0.75